期刊
KIDNEY INTERNATIONAL
卷 99, 期 5, 页码 1179-1188出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2020.07.046
关键词
artificial neural networks; clinical decision support system; endstage kidney disease; IgA nephropathy; joint models; machine learning
资金
- [ERA-EDTA 2009]
- [PON REC 02_00134/2011]
The study developed an artificial neural network prediction model for ESKD in IgAN patients, showing high performance values and recall rates over five and ten-year follow-ups. The model demonstrated successful results in an independent cohort and outperformed other mathematical models in discriminant indexes and calibration. The dynamic discrimination indexes of the artificial neural network remained consistent over a 25-year follow-up period, indicating its potential for accurately identifying high-risk individuals and predicting time-to-event endpoints.
We have developed an artificial neural network prediction model for end-stage kidney disease (ESKD) in patients with primary immunoglobulin A nephropathy (IgAN) using a retrospective cohort of 948 patients with IgAN. Our tool is based on a two-step procedure of a classifier model that predicts ESKD, and a regression model that predicts development of ESKD over time. The classifier model showed a performance value of 0.82 (area under the receiver operating characteristic curve) in patients with a follow-up of five years, which improved to 0.89 at the ten-year follow-up. Both models had a higher recall rate, which indicated the practicality of the tool. The regression model showed a mean absolute error of 1.78 years and a root mean square error of 2.15 years. Testing in an independent cohort of 167patients with IgAN found successful results for 91% of the patients. Comparison of our system with other mathematical models showed the highest discriminant Harrell C index at five- and ten-years follow-up (81% and 86%, respectively), paralleling the lowest Akaike information criterion values (355.01 and 269.56, respectively). Moreover, our system was the best calibrated model indicating that the predicted and observed outcome probabilities did not significantly differ. Finally, the dynamic discrimination indexes of our artificial neural network, expressed as the weighted average of time-dependent areas under the curve calculated at one and two years, were 0.80 and 0.79, respectively. Similar results were observed over a 25-year follow-up period. Thus, our tool identified individuals who were at a high risk of developing ESKD due to IgAN and predicted the time-to-event endpoint. Accurate prediction is an important step toward introduction of a therapeutic strategy for improving clinical outcomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据